Day One Expands Pipeline with Potential First-in-Class Clinical …
WEBJun 18, 2024 · Inspired by “The Day One Talk” that physicians have with patients and their families about an initial cancer diagnosis and treatment plan, Day One aims to re-envision cancer drug...
Day One’s OJEMDA™ (tovorafenib) Receives US FDA Accelerated …
WEBApr 23, 2024 · Day One partners with leading clinical oncologists, families, and scientists to identify, acquire, and develop important targeted cancer treatments. The Company’s pipeline includes tovorafenib (OJEMDA™) and pimasertib.
Breaking News, Latest News and Videos | CNN
WEBView the latest news and breaking news today for U.S., world, weather, entertainment, politics and health at CNN.com.
Press Releases - Day One Biopharmaceuticals, Inc.
WEBJan 17, 2024 · Day One Expands Pipeline with Potential First-in-Class Clinical-Stage Antibody Drug Conjugate (ADC) Targeting PTK7 in Solid Tumors for Adult and Pediatric Cancers. May 30, 2024. Day One Announces Sale of Priority Review Voucher for $108 Million. May 06, 2024.
Day One Expands Pipeline with Potential First-in-Class Clinical …
WEBJun 18, 2024 · Day One partners with leading clinical oncologists, families, and scientists to identify, acquire, and develop important targeted cancer treatments. The Company’s pipeline includes tovorafenib (OJEMDA™) and pimasertib.
Day One Biopharmaceuticals, Inc. (DAWN) - Stock Analysis
WEB3 days ago · Get a real-time Day One Biopharmaceuticals, Inc. (DAWN) stock price quote with breaking news, financials, statistics, charts and more.
Day One Biopharmaceuticals, Inc. (DAWN) - Yahoo Finance
WEBFind the latest Day One Biopharmaceuticals, Inc. (DAWN) stock quote, history, news and other vital information to help you with your stock trading and investing.
Day One Announces $130 Million Series B Financing to Accelerate …
WEBFeb 10, 2021 · SAN FRANCISCO-- ( BUSINESS WIRE )--Day One Biopharmaceuticals, a clinical-stage biopharmaceutical company focused on accelerating new, promising targeted therapies for children and adults with...
Day One | Advancing Targeted Therapies | Clinical Trials
WEBLearn about clinical trials at Day One, a biopharmaceutical company advancing targeted therapies for people of all ages with life-threatening diseases.
Day One | Targeted Therapies for Patients of All Ages | Home
WEBJoin our team as we work together to develop medicines that make a difference for patients. Day One Biopharmaceuticals is a clinical-stage company dedicated to developing and commercializing innovative targeted therapies for patients of all ages.
- Some results have been removed
Skip to content